4 Programs

Covaxin showed better antibody response in 2-18 year olds than adults: Bharat Biotech – Times of India

admin
  1. Covaxin showed better antibody response in 2-18 year olds than adults: Bharat Biotech  Times of India
  2. Are India’s latest covid-19 vaccines more effective?  Mint
  3. Quixplained: India’s vaccination program for children of 15-18 yrs  The Indian Express
  4. Covaxin shows robust safety, immunogenicity in 2-18-year-olds: Bharat Biotech reveals clinical trial data  Deccan Herald
  5. Govt allows export of 7 crore Covovax vaccine doses to Netherlands, Australia, New Zealand  India Today
  6. View Full coverage on Google News